RSS

Bria-IMT

A research team from immuno-oncology focused biotechnology company, BriaCell Therapeutics, has published a paper shedding light on the potentially unique mechanism of action of the company’s lead product candidate, Bria-IMT, at shrinking tumours. more

News

An immune-oncology focused biotechnology company, BriaCell, has provided a clinical update on its lead immunotherapy drug for advanced breast cancer. more

News